Home/Filings/4/0001209191-10-061439
4//SEC Filing

Feeney John Joseph 4

Accession 0001209191-10-061439

CIK 0001347178other

Filed

Dec 16, 7:00 PM ET

Accepted

Dec 17, 5:03 PM ET

Size

8.4 KB

Accession

0001209191-10-061439

Insider Transaction Report

Form 4
Period: 2010-12-16
Feeney John Joseph
Acting Chief Medical Officer
Transactions
  • Award

    Employee Stock Option (Right to Buy)

    2010-12-16+56,25056,250 total
    Exercise: $8.75Exp: 2020-12-15Common Stock (56,250 underlying)
  • Award

    Restricted Stock Units

    2010-12-16+18,75018,750 total
    Common Stock (18,750 underlying)
Footnotes (4)
  • [F1]The option vests in 48 equal monthly installments beginning on January 16, 2011.
  • [F2]The Restricted Stock Units represent a contingent right to receive a share of the Issuer's common stock.
  • [F3]The Restricted Stock Units vest in four equal annual installments beginning January 1, 2012. Vested shares will be delivered on the First Permissable Trading Day (as defined in the Restricted Stock Unit Agreement) that occurs on or after the day when the Restricted Stock Units vest.
  • [F4]N/A

Issuer

Vanda Pharmaceuticals Inc.

CIK 0001347178

Entity typeother

Related Parties

1
  • filerCIK 0001454240

Filing Metadata

Form type
4
Filed
Dec 16, 7:00 PM ET
Accepted
Dec 17, 5:03 PM ET
Size
8.4 KB